CTNM
Price
$3.90
Change
+$0.04 (+1.04%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
99.09M
SVRA
Price
$2.92
Change
+$0.01 (+0.34%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
502.96M
77 days until earnings call
Interact to see
Advertisement

CTNM vs SVRA

Header iconCTNM vs SVRA Comparison
Open Charts CTNM vs SVRABanner chart's image
Contineum Therapeutics
Price$3.90
Change+$0.04 (+1.04%)
Volume$1.7K
Capitalization99.09M
Savara
Price$2.92
Change+$0.01 (+0.34%)
Volume$27.48K
Capitalization502.96M
CTNM vs SVRA Comparison Chart
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. SVRA commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and SVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CTNM: $3.86 vs. SVRA: $2.91)
Brand notoriety: CTNM and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 98% vs. SVRA: 121%
Market capitalization -- CTNM: $99.09M vs. SVRA: $502.96M
CTNM [@Biotechnology] is valued at $99.09M. SVRA’s [@Biotechnology] market capitalization is $502.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, CTNM is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 4 TA indicator(s) are bullish while SVRA’s TA Score has 4 bullish TA indicator(s).

  • CTNM’s TA Score: 4 bullish, 4 bearish.
  • SVRA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than SVRA.

Price Growth

CTNM (@Biotechnology) experienced а +0.39% price change this week, while SVRA (@Biotechnology) price change was -2.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

CTNM is expected to report earnings on May 15, 2025.

SVRA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($503M) has a higher market cap than CTNM($99.1M). SVRA YTD gains are higher at: -5.212 vs. CTNM (-73.686). CTNM has higher annual earnings (EBITDA): -42M vs. SVRA (-88.58M). SVRA has more cash in the bank: 219M vs. CTNM (205M). CTNM has less debt than SVRA: CTNM (6.26M) vs SVRA (26.7M). CTNM (0) and SVRA (0) have equivalent revenues.
CTNMSVRACTNM / SVRA
Capitalization99.1M503M20%
EBITDA-42M-88.58M47%
Gain YTD-73.686-5.2121,414%
P/E Ratio26.40N/A-
Revenue00-
Total Cash205M219M94%
Total Debt6.26M26.7M23%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTNMSVRA
RSI
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
69%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFRJX58.26N/A
N/A
MFS Research R4
CMCIX26.59N/A
N/A
Calvert Small/Mid-Cap I
GVIYX12.04N/A
N/A
GuideStone Funds Value Equity Idx Instl
BMEAX23.69N/A
N/A
BlackRock High Equity Income Investor A
EISAX26.43N/A
N/A
Carillon ClariVest Intl Stock A

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with GUTS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then GUTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+0.65%
GUTS - CTNM
34%
Loosely correlated
-12.38%
CCCC - CTNM
34%
Loosely correlated
-8.11%
SLN - CTNM
31%
Poorly correlated
N/A
ARMP - CTNM
29%
Poorly correlated
-6.67%
SVRA - CTNM
28%
Poorly correlated
-7.18%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with LRMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-7.18%
LRMR - SVRA
48%
Loosely correlated
-6.31%
KYMR - SVRA
45%
Loosely correlated
-4.17%
CRNX - SVRA
43%
Loosely correlated
-4.53%
ATXS - SVRA
43%
Loosely correlated
-8.62%
CCCC - SVRA
42%
Loosely correlated
-8.11%
More